Physician profile
Gary Martin
NPI 1750329918
$12,316.99
in general payments reported to CMS, 2019-2025
52 companies · $1,665 in 2025
The $1,665 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,039 · 2020: $1,573 · 2021: $2,260 · 2022: $1,334 · 2023: $1,620 · 2024: $1,826 · 2025: $1,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,110.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,492.42 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $1,323.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,080.18 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $998.09 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $828.88 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $801.01 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $404.25 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $391.48 | 2019-2025 | |
| Amgen INC. | $368.92 | 2019-2023 | Prolia, Evenity |
| Supernus Pharmaceuticals, INC. | $358.20 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $255.49 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $191.17 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $183.38 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $177.15 | 2019-2023 | |
| Esperion Therapeutics, INC. | $173.52 | 2020-2025 | Nexletol |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $173.15 | 2019-2024 | Veozah, Myrbetriq |
| Phathom Pharmaceuticals, INC. | $173.09 | 2024-2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $148.99 | 2020-2024 | Linzess |
| Allergan, INC. | $143.90 | 2019-2020 | |
| Indivior INC. | $131.82 | 2019-2023 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $131.02 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $111.94 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $110.14 | 2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $95.86 | 2019-2024 | Gattex |
| Merck Sharp & Dohme LLC | $88.03 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Otsuka America Pharmaceutical, INC. | $79.31 | 2021-2025 | Rexulti |
| Boston Scientific Corporation | $78.10 | 2022-2023 | Exalt Model D |
| Viatris Specialty LLC | $73.72 | 2025 | Yupelri |
| Abbott Laboratories | $69.96 | 2023-2024 | Freestyle Libre 3 |
| Mylan Specialty L.P. | $69.39 | 2019-2023 | Yupelri |
| Axsome Therapeutics, INC. | $68.21 | 2025 | Auvelity |
| Dexcom, INC. | $58.38 | 2023-2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $55.87 | 2024-2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $55.29 | 2022-2023 | Quviviq |
| Eisai INC. | $44.55 | 2019-2021 | |
| Amarin Pharma, INC. | $38.89 | 2020-2021 | |
| Corcept Therapeutics | $29.27 | 2024 | Korlym |
| Nestle Healthcare Nutrition INC. | $29.23 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $24.44 | 2019 | |
| Shire North American Group INC | $24.32 | 2019 | |
| Lundbeck LLC | $23.36 | 2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $19.88 | 2025 | Fanapt |
| Verona Pharma, INC. | $19.83 | 2025 | Ohtuvayre |
| Corium, LLC | $18.40 | 2024 | Azstarys |
| Tonix Medicines, INC. | $14.44 | 2025 | Tonmya |
| Kowa Pharmaceuticals America, INC. | $13.49 | 2025 | Zoryve |
| Abiomed | $13.13 | 2024 | Impella |
| Almatica Pharma LLC | $12.50 | 2021 | |
| Genentech USA, INC. | $12.44 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.17 | 2019 | |
| Zyla Life Sciences, INC. | $11.50 | 2020 | |
| Sanofi Pasteur INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.